Thứ Ba, 1 tháng 11, 2011

Shortage of medical treatment due to death of prisoner Yan Sok Kea

CAMBODIAN HUMAN RIGHTS AND DEVELOPMENT ASSOCIATION
pÞHelx3 pøÚv158 b¤]kja:eRTOgkag sgáat;bwgvaMg xNÐdUneBj
No: 3, St 158 Oukghna Toeung Kang, Beng Raing Daun Penh P.P
Tel: (855-23) 218653 & 990544 Fax: (855-23) 217229 P.O. Box: 1024 P.O. Box 20 at CCC
E-mail : adhoc@forum.org.kh Web: www.adhoc-chra.org

Public Statement

Shortage of Health Treatment for Prisoner and Delayed until Yan Sok Kea die

The Human Rights and Development Association (ADHOC) strongly condemn about shortage of health treatment for a suspect Yan Sok Kea becoming seriously ill and also condemn about medical viagra cialis online pharmacy pharmacy is delayed and negligent to let Yan Sok Kea die fatefully.

Yan Sok Kea was innocent, arrested by theory of not mistake of police, he was indicted of “destruction of nature”by Phnom Penh court which processes until now this case is not yet rightfully investigated. Yan Sok Kea is healthy when he was arrested by police then he was sent from Preahvihear province on November 14, 2008 for temporary detention in the correction center 1 “Preysar ” where he had got high fever for several days without treatment until he become unconscious and his limb become unmovable then he was sent lately to Preah Monivong hospital. Yan Sok Kea is hospitalized in Preahmonivong from April 12, 2008 until April 24, 2008 when medical doctor was negligent, not carefully and treat in risk without medical consultation but in contrast doctor muttered about lack of medicine, no budget, no modern medical tool; doctor did to take action to save life of Yan Sok Kea and delayed until he die momentously without treatment likely to life of animal.

Even if there are several times of intervention by Human Rights Organizations but procedure and style of bureaucracy in transfer Yan Sok Kea to modern hospital is so late that is lead Yan Sok Kea to die in Hospital of Cambodia-Russia friendship on April 28, 2008 without awareness of result of consultation.

ADHOC insist to Government to pay more attention again to examine thoroughly in treatment of prisoner’s health and medical service of patient in hospital in avoid of allowing patient as Yan Sok Kea die hazardously anymore, likely to life of animal without treatment following the United Nations Rule of Minimum Standard forTtreatment of Prisoner. Furthermore ADHOC urge to Government to penalize all involved officials who make prisoner died and especially ADHOC request for all level of court have to investigate rightfully before imprisonment and make human life considered as in vain without responsibility in duty.
Phnom Penh on April 28, 2008

Further information please contact to:
-Mr. Chakrya Ny, Head of monitoring ADHOC H.P : 011 27 49 59
-Mr. Soveth Chan, Human Rights Officer ADHOC H.P : 016 93 75 91

Thứ Bảy, 29 tháng 10, 2011

For the love of Cialis

See also: online pharmacy | 


Looks like fate has brought me back to this blog and I find myself updating again. It has been over a year since I last posted, and I say it over and over, but it's hard to believe how fast it's gone. I find myself in marketing today, doing all sorts of marketing work, advertising, promo stunts, subliminal messages, direct brainwashing etc. but that makes me by no means an expert yet...

Hilariously, I come back to this humble blog to find Viagra spam in the comments below. Now, I would be quick to dismiss this as shady and ineffective advertising (and fucking annoying), but my friend Luke was quick to derail this train of thought with a marvellous gem of lateral thinking.

Name two penis enhancing drugs that you know of?

Most of you will say 'Viagra' and 'Cialis'. Consider me blown away. It's actually marketing genius.

Thứ Hai, 23 tháng 5, 2011

How to Use Cascara Sagrada as a Constipation Remedy

See also: cheap cialis | 


Cascara Sagrada comes from the bark of the buckthorn tree. It stimulates your colon to produce stronger contraction than normal. When it does this, it can work on the most difficult and chronic cases of constipation. It is one of the herbal constipation remedies with a strong laxative effect. It will be found in many herbal combinations that are mixed for constipation. Cascara has Chrysophanic acid, which stimulates your colon wall to produce peristaltic action. Cascara also contains a chemical called emodin, which controls the strong action of Chrysophonic acid thus producing a balanced laxative effect.If you use cascara in a constipation remedy mixture, do not use this mixture for more than thirty days. After 30 days take a rest from it. Do not use Cascara in large amounts and for long periods since it can cause intestinal distress and become habit-forming. When you use it, you will see results in 1-2 days.Cascara Sagrada also stimulates secretions from the liver, gallbladder, pancreas, and stomach. These secretions give Cascara additional laxative effects.Do not use Cascara Sagrada if you have irritable bowel syndrome, hemorrhoids, or ulcers. Use Cascara for a limited time. It can become habit-forming and, if used for an extended time, it can increase the risk of colon cancer. Its use also causes you to lose potassium with each bowel movement.If you have liver problems do not use cascara sagrada full strength. Use it in combination with other herbs. Cascara is known to put a strain on the liver.You can take Cascara Sagrada as a single herb for constipation. As a single herb, it can cause cramping and nausea. However, I recommend you used it with other herbs. In an herbal combination, the combination can detoxify your colon, tonify your colon walls, cleanse the blood and produce other synergistic actions.In Michael Murray, N.D., book called The Pill Book Guide to Natural Medicines, he talks about the drug interaction of cascara sagrada,“Cascara and other stimulant laxatives may decrease absorption of other drugs that pass through the gastrointestinal tract. If you are currently taking an oral cheap viagra, talk to your pharmacist or doctor before self-medicating with cascara.Cascara may potentiate the action of digoxin and other heart medications due to potassium depletion. The use of cascara with thiazide diuretics and corticosteroids may further decrease potassium levels.”Recommend dose for the cascara sagrada, as a single herb, is 350 – 1000mg just before bedtime.Use 1-4 cascara sagrada powder capsules a night, but do not use these capsules for more than 10 days. Start with 1 capsule a night and increase the amount each day until you get results you want.For a laxative tea, use one teaspoon of cascara bark in 3 cups of boiling water for 20 minutes. Drink 1-2 cups of tea just before bedtime after it has cooled to room temperature.Cascara Sagrada is a strong constipation remedy and will help you clean out your colon even if you have chronic constipation. Use it sparely and for a short time.

Thứ Ba, 3 tháng 5, 2011

Boehringer Ingelheim’s lead hepatitis C compound moves into Phase III – the first within the BI HCV portfolio


• FDA Fast Track designations granted for both: the protease purchase cialis BI 201335 plus standard-of-care and the interferon-free combination of BI 201335 with polymerase cheap cialis, BI 207127

INGELHEIM, Germany - Saturday, April 2nd 2011 [ME NewsWire]

(BUSINESS WIRE)-- Boehringer Ingelheim today announced the study outline for the pivotal Phase III clinical trials designed to evaluate BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naïve and -experienced patients with chronic genotype-1 hepatitis C virus (HCV), the most challenging genotype to treat.

In parallel, the U.S. Food and Drug Administration (FDA) has granted Fast Track designations for BI 201335 plus standard-of care (SOC), and as part of the interferon-free combination with the polymerase inhibitor, BI 207127, in chronic genotype-1 HCV patients.

“We are delighted to receive the FDA’s Fast Track designation for both, our BI 201335 plus SOC, and interferon-free combination treatment approaches. If successful, the combination therapy carries the potential for patients to live without the burden of interferon’s side effects,” said Professor Klaus Dugi, Corporate Senior Vice President Medicine at Boehringer Ingelheim.

“We are committed to bringing BI 201335 forward, with the ambition of improving cure rates for the benefit of those living with hepatitis C.”

BI 201335 Phase III Trials*

BI 201335 will be evaluated in multiple randomised, double-blind, placebo-controlled trials in combination with pegylated-interferon and ribavirin (PegIFN/RBV), the current HCV SOC. The Phase III trials include two studies in treatment-naïve and one study in treatment-experienced chronic genotype-1 HCV patients. The two studies in treatment-naïve patients will be conducted in the European Union and Japan, as well as the U.S., Canada, Taiwan and Korea. The study in treatment-experienced patients will be conducted globally. BI 201335 will be dosed once-daily at either 120mg or 240mg in combination with PegIFN/RBV and treatment durations will range from 24 to 48 weeks. The primary endpoint of each trial is sustained viral response (SVR), which is considered viral cure. These studies are part of a broader Phase III trial programme expected to commence in the second quarter of 2011.

PegIFN-Free Phase II Trials of BI 201335 + BI 207127

In parallel, Boehringer Ingelheim is developing BI 207127, an oral HCV polymerase inhibitor that has completed Phase I clinical trials in combination with BI 201335. Phase II trials evaluating BI 207127 plus BI 201335 in PegIFN-free regimens, both with and without ribavirin, are currently underway. The FDA has designated this investigation as a Fast Track development programme. Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious diseases and fill an unmet medical need. The purpose is to get important new drugs to patients earlier.

*Final results of the Phase II studies SILEN-C1 and SILEN-C2 for BI 201335 were presented yesterday at the International Liver CongressTM 2011, the 46th Annual Meeting of the European Association for the study of the liver (EASL) in Berlin.

About Hepatitis C Virus (HCV)

HCV is an infectious disease of the liver and is a leading cause of chronic liver disease and liver transplant. The number of individuals chronically infected with HCV globally has been estimated at 170 million, with 3–4 million new infections occurring each year. Only about 20–45% of patients clear the virus in the acute phase. Of the remaining chronically infected patients, 20% will develop cirrhosis within a mean of 20 years. The mortality rate after cirrhosis has developed is 2-5% per year. End-stage liver disease due to HCV infection currently represents the major cause for liver transplantation in the Western world.

About Boehringer Ingelheim in Virology

Boehringer Ingelheim has more than 6,900 scientists working in cross disciplinary teams within our global R&D network in six large therapeutic areas, including virology. In addition to its ongoing research programme for HCV, Boehringer Ingelheim has a long-standing history in virology drug development, including compounds for the treatment of HIV (VIRAMUNE® (nevirapine) tablets/oral suspension, the first approved HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) and Aptivus®, an HIV protease inhibitor). The company has a well established research centre in Laval, Canada, dedicated to virology research since the early 1990’s, and is committed to developing new therapies for virological diseases with a high unmet medical need.

Boehringer Ingelheim in Hepatitis C Virus (HCV)

BI 201335 is an investigational oral HCV NS3/4A protease inhibitor, discovered from Boehringer Ingelheim’s own research and development, which has completed clinical trials through Phase IIb (SILEN-C studies). This Phase II programme supports the investigation of BI 201335 in Phase III trials. Boehringer Ingelheim is also developing BI 207127, an NS5B RNA-dependent polymerase inhibitor that has completed Phase I clinical trials. Phase II trials evaluating BI 207127 with BI 201335 in interferon-sparing regimens, both with and without ribavirin, are currently underway.

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro (US $17.7 billion) while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit www.boehringer-ingelheim.com

www.twitter.com/boehringer

Boehringer Ingelheim GmbH

CD Communications

Binger Straße 173 D-55216 Ingelheim am Rhein

www.boehringer-ingelheim.com

Phone +49 6132 77-8271 Fax +49 6132 77-7077

Contacts

Boehringer Ingelheim GmbH

Julia Meyer-Kleinmann,

Director Corporate Communications

+ 49 - 6132 – 77 8271

press@boehringer-ingelheim.com

generation

cheap cialis side effect
cialis professi9nal cialis professi9nal cailis levitra cialis side effeccts calis dosage cialis picturs cialis sids effects cialis professinal GugguluAvaproTenorminMonoketIsordilLipitorAceonAldactoneAltaceCapotenCardizemCarduraCoregCozaarCrestorDiovanHytrinInnoPran cialis dosahe viabra cialis cialis pictjre scieViagra cialis picure viagra ciais cialis domparison levitra viagra levitra vs cialis side ffects levjtra vs cialis side effects cialis levitraa how does cislis work lebitra vs cialis side effects cialis side efdects cialis pevitra cizlis dosage how does cialis qork cialis comparkson levitra viagra vagra vs cialis ciallis levitra ho2 does cialis work designed cialis dosave ciialis side effects levitra vs cialis s9de effects cilais levitra how does cialis wwork Enhancement cialis com0arison levitra viagra viagra vss cialis blood viagra cialiis scientifically cialis comparison levitra vkagra cialis aide effects inhalerMedrolRhinocortSereventVentolinClarinex cials comparison levitra viagra levitra vs cialis side effecfs natural how does cialis wodk cialis lecitra viagda cialis 417Cialis Checkout cialis professionwl cialis pdofessional safety potency how des cialis work cialis pictuee cialis skde effects cailis side effects viagra vs fialis Plasma cialis lecitra levitra vs cialis side effecta Penis ciqlis professional cialis comparison levitra viaga viagra ciaois levitra vvs cialis side effects policyMoneyback how ddoes cialis work viagra bs cialis erectile ciali scomparison levitra viagra policyPrivacy cialis side effdcts levitra vs cialis side ecfects viagra vs ciaois StandardJust cilis comparison levitra viagra how does cialis wofk levitra vs cialis zide effects safety vizgra vs cialis ciali levitra cialis comparison levjtra viagra cilais levitra viagda vs cialis cialiis professional viagra cials Checkout Canada DGeriforteAriceptReviaParlodelHydreaElimite levirta vs cialis side effects how does cilis work Levitra how does cialsi work levitra vs cialis sife effects cialis profwssional ccialis levitra cialis comparison levi5ra viagra quickly cials levitra ccialis side effects ciais dosage cialis professuonal cial9s side effects levitrz vs cialis side effects reduced viagra vs cjalis 7871711 ciakis comparison levitra viagra levitra vs cialis xide effects ho2 does cialis work levitra vs ialis side effects accept levitra vs cialis sde effects how does ciallis work resulted treatment kevitra vs cialis side effects cialis ipcture ciails comparison levitra viagra xialis dosage 14409Phentrimine cialis comparson levitra viagra cialis side effcets PatchHoodia viagra vs cialis Whitening GelBreast levigra vs cialis side effects pevitra vs cialis side effects levitra vs cialis side effecst viagra vs xialis cialis levitea viagra vx cialis cialis profesisonal Smoking vialis levitra cial8s levitra levitra vs cialis sidr effects how doee cialis work ciwlis professional cialis pevitra how foes cialis work lrvitra vs cialis side effects cialis p8cture ciali picture cislis picture cialis prkfessional levitra vs cialia side effects cialis picutre cial9s comparison levitra viagra Growth lveitra vs cialis side effects ciails comparison levitra viagra cialis compadison levitra viagra how does cializ work Growth cialis pictu4e cialis side effec6s Having productsCalcium includes ciails side effects levitra va cialis side effects cialis side etfects cialis comparison levitra v8agra viagra vs icalis viagra vx cialis Pills ciails dosage ViagraTramadol cialis side effedts madicationPenis vialis comparison levitra viagra viagra vs ciqlis cialis pictufe comparison how xoes cialis work cialis pevitra cial9s levitra variety cialis profesisonal TabsJust SRCalanPrinivilSorbitrateInderalAdalatLopressorIsoptinCoumadinAbanaall c9alis levitra cializ comparison levitra viagra levitra vs dialis side effects how does ciialis work cialiss levitra levitra vs cialis side effcts spamContact cizlis levitra cialiss levitra levitra vs cialis side egfects PatchPenis cialis comparison levitra vagra levitra vs cialis side effects